167 related articles for article (PubMed ID: 7677784)
1. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
Yoshida T; Tsuda H
Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
[TBL] [Abstract][Full Text] [Related]
2. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
Begleiter A; Leith MK
Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
4. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
5. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
Yao KS; Hageboutros A; Ford P; O'Dwyer PJ
Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597
[TBL] [Abstract][Full Text] [Related]
6. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
Begleiter A; Robotham E; Leith MK
Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799
[TBL] [Abstract][Full Text] [Related]
7. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
Lambert PA; Kang Y; Greaves B; Perry RR
J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.
Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A
Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
[TBL] [Abstract][Full Text] [Related]
10. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
Begleiter A; Leith MK; Curphey TJ; Doherty GP
Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
[TBL] [Abstract][Full Text] [Related]
13. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1037-41. PubMed ID: 7685584
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
Halinska A; Belej T; O'Brien PJ
Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
Wu K; Eng E; Knox R; Chen S
Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
[TBL] [Abstract][Full Text] [Related]
16. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Gasdaska PY; Fisher H; Powis G
Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs.
Powis G; Gasdaska PY; Gallegos A; Sherrill K; Goodman D
Anticancer Res; 1995; 15(4):1141-5. PubMed ID: 7653992
[TBL] [Abstract][Full Text] [Related]
18. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
Dulhanty AM; Whitmore GF
Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
[TBL] [Abstract][Full Text] [Related]
19. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
20. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells.
Schlager JJ; Hoerl BJ; Riebow J; Scott DP; Gasdaska P; Scott RE; Powis G
Cancer Res; 1993 Mar; 53(6):1338-42. PubMed ID: 8443814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]